Renoprotection by enzyme replacement therapy
- 1 March 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 13 (2), 231-241
- https://doi.org/10.1097/00041552-200403000-00012
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapyKidney International, 2002
- Natural History of Fabry Renal DiseaseMedicine, 2002
- Enzyme replacement therapy for Fabry disease, an inherited nephropathyClinical Nephrology, 2002
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous malesJournal of Medical Genetics, 2001
- Anderson–Fabry disease: Clinical manifestations of disease in female heterozygotesJournal of Inherited Metabolic Disease, 2001
- Renal disease in Fabry patientsJournal of Inherited Metabolic Disease, 2001
- Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry’s diseaseThe American Journal of Cardiology, 2001
- Prevalence of Lysosomal Storage DisordersJAMA, 1999
- Kidney Involvement in Anderson-Fabry DiseasePublished by S. Karger AG ,1997
- Early renal changes in hemizygous and heterozygous patients with Fabry's diseaseKidney International, 1978